Craig Bijou
Stock Analyst at B of A Securities
(3.85)
# 576
Out of 4,832 analysts
62
Total ratings
64.71%
Success rate
61.54%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $53.04 | +58.37% | 4 | Apr 25, 2025 | |
RXST RxSight | Maintains: Buy | $60 → $36 | $13.20 | +172.73% | 1 | Mar 21, 2025 | |
TFX Teleflex | Downgrades: Underperform | $235 → $140 | $126.80 | +10.41% | 5 | Mar 4, 2025 | |
BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $11.76 | +44.56% | 3 | Feb 20, 2025 | |
GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $58.25 | +66.52% | 4 | Jan 9, 2025 | |
IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $13.51 | +33.23% | 13 | Oct 7, 2024 | |
ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $121.00 | +19.83% | 3 | Oct 1, 2024 | |
MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $97.61 | +5.52% | 3 | Sep 16, 2024 | |
HAE Haemonetics | Initiates: Neutral | $85 | $69.14 | +22.94% | 1 | Sep 11, 2024 | |
GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $73.83 | +16.48% | 2 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $81.76 | +16.19% | 1 | Oct 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $18.59 | +93.65% | 2 | Jan 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.19 | +626.98% | 3 | May 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1 → $8 | $0.45 | +1,688.11% | 2 | Mar 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.72 | +535.59% | 5 | Mar 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $9.81 | +32.52% | 2 | Mar 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $12.49 | +236.27% | 3 | Feb 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $563.95 | -59.22% | 1 | Jan 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $387.53 | -40.65% | 4 | Jul 26, 2019 |
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $53.04
Upside: +58.37%
RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60 → $36
Current: $13.20
Upside: +172.73%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $126.80
Upside: +10.41%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $11.76
Upside: +44.56%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $58.25
Upside: +66.52%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $13.51
Upside: +33.23%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $121.00
Upside: +19.83%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $97.61
Upside: +5.52%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $69.14
Upside: +22.94%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $73.83
Upside: +16.48%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $81.76
Upside: +16.19%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $18.59
Upside: +93.65%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.19
Upside: +626.98%
Mar 25, 2020
Maintains: Overweight
Price Target: $1 → $8
Current: $0.45
Upside: +1,688.11%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $4.72
Upside: +535.59%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $9.81
Upside: +32.52%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $12.49
Upside: +236.27%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $563.95
Upside: -59.22%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $387.53
Upside: -40.65%